Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B

BACKGROUND: Whether different anti-hepatitis B virus (HBV) drugs have different effects on COVID-19 is controversial. We aimed to evaluate the incidence of COVID-19 in chronic hepatitis B (CHB) patients receiving anti-HBV treatment, and to compare the impact of entecavir (ETV) and tenofovir disoprox...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xingmei, Fan, Yujie, Zhong, Chunxiu, Zhao, Siru, Guo, Liangxu, Tan, Wenjuan, Yin, Junhua, Fan, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688146/
https://www.ncbi.nlm.nih.gov/pubmed/38036959
http://dx.doi.org/10.1186/s12879-023-08838-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688146/
https://www.ncbi.nlm.nih.gov/pubmed/38036959
http://dx.doi.org/10.1186/s12879-023-08838-0

Ejemplares similares